Insmed (NSM) Doses First Patient in ARIKACE Phase 2

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/26/2026

1. INTC
2. DECK
3. AMD
4. META
5. INFY
6. RNG
7. TMUS
8. SPY
9. UNP
10. GOOGL

Go back to Insmed (NSM) Doses First Patient in ARIKACE Phase 2
INSMED (NASDAQ: INSM) Delayed: 106.92 -0.49 (0.46%)
Previous Close $107.41    52 Week High $19.30 
Open $106.49    52 Week Low $9.02 
Day High $108.27    P/E N/A 
Day Low $105.77    EPS $-1.69 
Volume 1,908,294